| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/02713689508998529 |
| P698 | PubMed publication ID | 8585935 |
| P2093 | author name string | R M Strieter | |
| S L Kunkel | |||
| G J Jaffe | |||
| S G Elner | |||
| V M Elner | |||
| A Stuart | |||
| P433 | issue | 11 | |
| P921 | main subject | proliferative diabetic retinopathy | Q18967481 |
| diabetic retinopathy | Q631361 | ||
| proliferative vitreoretinopathy | Q7249608 | ||
| P304 | page(s) | 1045-1053 | |
| P577 | publication date | 1995-11-01 | |
| P1433 | published in | Current Eye Research | Q5195042 |
| P1476 | title | Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy | |
| P478 | volume | 14 |
| Q96109569 | A Review of Last Decade Developments on Epiretinal Membrane Pathogenesis |
| Q47230436 | A novel and less invasive technique to assess cytokine profile of vitreous in patients of diabetic macular oedema |
| Q35679523 | A novel strategy to develop therapeutic approaches to prevent proliferative vitreoretinopathy |
| Q36990241 | Adeno-Associated Virus Overexpression of Angiotensin-Converting Enzyme-2 Reverses Diabetic Retinopathy in Type 1 Diabetes in Mice. |
| Q33845524 | Alterations in the intraocular cytokine milieu after intravitreal bevacizumab |
| Q44115911 | An in vitro model of the back of the eye for studying retinal pigment epithelial-choroidal endothelial interactions |
| Q40920806 | Analysis of the secretion pattern of monocyte chemotactic protein-1 (MCP-1) and transforming growth factor-beta 2 (TGF-beta2) by human retinal pigment epithelial cells |
| Q36490463 | Angiogenesis-related cytokines in serum of proliferative diabetic retinopathy patients before and after vitrectomy |
| Q41883466 | Angiogenic Factors and Cytokines in Diabetic Retinopathy |
| Q33990716 | Apelin in epiretinal membranes of patients with proliferative diabetic retinopathy. |
| Q38941639 | Application of multiplex immunoassay technology to investigations of ocular disease |
| Q92219696 | Aqueous Humor Mediator and Cytokine Aberrations in Diabetic Retinopathy and Diabetic Macular Edema: A Systematic Review and Meta-Analysis |
| Q36324073 | Aqueous cytokine levels are associated with reduced macular thickness after intravitreal ranibizumab for diabetic macular edema |
| Q33745645 | Association of preoperative vitreous IL‐8 and VEGF levels with visual acuity after vitrectomy in proliferative diabetic retinopathy |
| Q90975056 | Characterisation of the inflammatory cytokine and growth factor profile in a rabbit model of proliferative vitreoretinopathy |
| Q99581462 | Comparative Analysis of Multiplex Platforms for Detecting Vitreous Biomarkers in Diabetic Retinopathy |
| Q35891554 | Comparison of aqueous humor cytokine and chemokine levels in diabetic patients with and without retinopathy. |
| Q33517638 | Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases |
| Q34166698 | Constitutive and LPS-induced expression of MCP-1 and IL-8 by human uveal melanocytes in vitro and relevant signal pathways |
| Q36952264 | Control of chemokine gradients by the retinal pigment epithelium. |
| Q35179240 | Current knowledge on diabetic retinopathy from human donor tissues |
| Q90607435 | Cytokine profiles of phakic and pseudophakic eyes with primary retinal detachment |
| Q41625920 | Cytokines: their role in uveal disease |
| Q58767141 | Cytotoxic effect of interleukin-8 in retinal ganglion cells and its possible mechanisms |
| Q43094228 | Detection of cytokine mRNA production in infiltrating cells in proliferative vitreoretinopathy using reverse transcription polymerase chain reaction. |
| Q38542115 | Diabetic Retinopathy: Vascular and Inflammatory Disease. |
| Q36082591 | Diabetic periodontitis: a model for activated innate immunity and impaired resolution of inflammation |
| Q41012046 | Diabetic retinopathy and inflammation: novel therapeutic targets. |
| Q37362491 | Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness. |
| Q39884097 | Effects of (-)-epigallocatechin gallate on RPE cell migration and adhesion. |
| Q34427717 | Enhanced PKCδ and ERK signaling mediate cell migration of retinal pigment epithelial cells synergistically induced by HGF and EGF. |
| Q33330334 | Feasibility study of chitosan as intravitreous tamponade material |
| Q58700008 | Human adipose tissue-derived stromal cells act as functional pericytes in mice and suppress high-glucose-induced proinflammatory activation of bovine retinal endothelial cells |
| Q34330943 | Human retinal pigment epithelial lysis of extracellular matrix: functional urokinase plasminogen activator receptor, collagenase, and elastase |
| Q30784200 | Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema |
| Q44804461 | Induction of IL-8, MCP-1, and bFGF by TNF-alpha in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation |
| Q28367730 | Induction of interleukin-8 in human retinal pigment epithelial cells after denuding injury |
| Q37095335 | Inflammatory biomarkers and progression of diabetic retinopathy in African Americans with type 1 diabetes |
| Q37626384 | Inflammatory mediators induced by amyloid-beta in the retina and RPE in vivo: implications for inflammasome activation in age-related macular degeneration |
| Q40617968 | Inhibitory effect of certain neuropeptides on the proliferation of human retinal pigment epithelial cells |
| Q28574646 | Intraocular expression and release of high-mobility group box 1 protein in retinal detachment |
| Q28361127 | Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy |
| Q58723006 | Intravitreal pro-inflammatory cytokines in non-obese diabetic mice: Modelling signs of diabetic retinopathy |
| Q42725230 | Lecithin-Bound Iodine Prevents Disruption of Tight Junctions of Retinal Pigment Epithelial Cells under Hypoxic Stress |
| Q78137580 | Lipid peroxidation in proliferative vitreoretinopathies |
| Q33803402 | Macrophage colony-stimulating factor and its receptor signaling augment glycated albumin-induced retinal microglial inflammation in vitro |
| Q35314709 | Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative diabetic retinopathy |
| Q81364368 | Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study |
| Q38050745 | Mechanisms of inflammation in proliferative vitreoretinopathy: from bench to bedside. |
| Q37734972 | Mesenchymal stem cells: new players in retinopathy therapy |
| Q42091159 | Microarray analysis identifies changes in inflammatory gene expression in response to amyloid-beta stimulation of cultured human retinal pigment epithelial cells |
| Q36222092 | Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes |
| Q73386173 | NF-?B in epiretinal membranes after human diabetic retinopathy |
| Q41955296 | Orbital fibroblast chemokine modulation: effects of dexamethasone and cyclosporin A. |
| Q43116460 | PDGF receptors are activated in human epiretinal membranes |
| Q47797906 | Periostin in vitreoretinal diseases. |
| Q50792998 | Pirfenidone inhibits post-traumatic proliferative vitreoretinopathy. |
| Q52609620 | Potential Interplay between Hyperosmolarity and Inflammation on Retinal Pigmented Epithelium in Pathogenesis of Diabetic Retinopathy. |
| Q77144020 | Proliferative vitreoretinopathy: an overview |
| Q34572836 | Proliferative vitreoretinopathy: risk factors and pathobiology |
| Q36817646 | Ranibizumab is a potential prophylaxis for proliferative vitreoretinopathy, a nonangiogenic blinding disease |
| Q37636807 | Recent developments in our understanding of how platelet-derived growth factor (PDGF) and its receptors contribute to proliferative vitreoretinopathy |
| Q82797683 | Reduced concentrations of angiogenesis-related factors in vitreous after vitrectomy in patients with proliferative diabetic retinopathy |
| Q58762933 | Remodeling of Retinal Architecture in Diabetic Retinopathy: Disruption of Ocular Physiology and Visual Functions by Inflammatory Gene Products and Pyroptosis |
| Q74151965 | Retinal detachment after posterior segment intraocular foreign body injuries |
| Q52642996 | Role of Inflammation in Diabetic Retinopathy. |
| Q41012127 | Role of inflammation in the pathogenesis of diabetic retinopathy |
| Q33633313 | Spatially and Temporally Regulated NRF2 Gene Therapy Using Mcp-1 Promoter in Retinal Ganglion Cell Injury |
| Q37071368 | Study of 27 aqueous humor cytokines in patients with type 2 diabetes with or without retinopathy |
| Q92512535 | Systemic Factors Related to Intraocular Levels of Interleukin-6 and Vascular Endothelial Growth Factor in Diabetic Retinopathy |
| Q26852726 | Targeting inflammation in diabetes: Newer therapeutic options |
| Q43929188 | The effect of partial vitrectomy on blood-ocular barrier function in the rabbit |
| Q51276675 | The gene polymorphisms of IL-8(-251T/A) and IP-10(-1596C/T) are associated with susceptibility and progression of type 2 diabetic retinopathy in northern Chinese population. |
| Q36906881 | The kinetics of VEGF and MCP-1 in the second vitrectomy cases with proliferative diabetic retinopathy |
| Q42373000 | Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy |
| Q28350939 | Thrombin regulates chemokine induction during human retinal pigment epithelial cell/monocyte interaction |
| Q90952571 | Utility of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for an In Vitro Model of Proliferative Vitreoretinopathy |
| Q35943908 | Vascular endothelial growth factor A competitively inhibits platelet-derived growth factor (PDGF)-dependent activation of PDGF receptor and subsequent signaling events and cellular responses |
| Q46624969 | Vitreous leptin levels in retinal disease |
Search more.